Financial

The software giant Salesforce announced this evening (Tuesday) the acquisition of the Israeli company Zoomin. The amount of the deal has not been published, but according to estimates the amount that Salesforce will pay in the first stage is approximately $350 million and may increase to $450 million after the addition of personal rewards to the company's employees and entrepreneurs, subject to a series of conditions

Teva Pharmaceutical Industries Ltd. announced a significant expansion of its collaboration with ambiance, focusing on developing biosimilar drugs—generic versions of biological medications created through the genetic engineering of mammalian cells or bacteria. This new agreement specifically targets a biosimilar version of an oncology drug from the PD-1 control protein blocker group

Teva Industries, the world’s largest manufacturer of generic drugs, has announced a $450 million settlement with the U.S. Department of Justice (DOJ). This settlement addresses multiple lawsuits alleging price coordination and fraudulent practices related to patient deductible coverage

As of the end of September, Israel's government deficit has reached 8.5% of GDP, amounting to approximately NIS 166 billion. This marks a 0.2% increase (about NIS 8.8 billion) from the previous month, reflecting escalating financial pressures related to ongoing military operations

McDonald's Israel will soon offer customers a free product with their online orders, following a class action settlement approved today (Tuesday) by the Central District Court in Lod. The settlement, which resolves claims of misleading pricing, will allow online orderers to select one free item from three options: a half-liter bottle of water (NIS 13), a 330 ml can of Coke Zero (NIS 10), or regular-sized fries (100 grams, NIS 18)

The Knesset plenum approved the state budget laws and the 2025 economic plan in a first reading late Monday night. The budget, totaling approximately 609 billion shekels, aims for a deficit target of 4.4%. The approval came amid significant political tensions surrounding disagreements within the ruling coalition

In a significant move for the Israeli medical technology sector, Boston Scientific has acquired the remaining 90% of shares in the Rehovot-based startup SoniVie for $360 million. The deal may increase by an additional $180 million depending on the achievement of certain milestones, a common arrangement in acquisitions within the field. This acquisition comes after Boston Scientific already owned a 10% stake in SoniVie

Israeli national airline El Al announced Monday that the state has officially lifted restrictions on dividend distribution, allowing the company to resume payouts to shareholders on profits from 2025, a year earlier than originally agreed